The aim of this WP is capacity building on regulatory and ethical aspects needed to ensure the process of vaccine/biomolecule development with respect to Good Clinical practices (GCP) standards aiming to (i) protect clinical trial subjects and (ii) ensure the integrity of data collected in clinical trials. 

By learning from regulatory authorities and pharmaceutical industry, trained academic talent will acquire expertise on interpretation and application of technical guidelines and requirements for pharmaceutical product registration according to the highest international norms with facility and efficiency.